Posted on:
Kolling researchers are set to lead a ground-breaking project to identify new drug therapies for those with Parkinson’s disease. The project has been made possible following Federal Government funding through the National Drug Discovery Centre. Senior Kolling researcher Dr Daniel Whiten has welcomed the announcement, saying the funding will help our team translate our scientific
Category:
Posted on:
Congratulations to the Kolling’s Executive Director Professor Carolyn Sue, elected a Fellow of the Australian Academy of Health and Medical Sciences for her outstanding contribution to health and medical research in Australia. Professor Sue is part of a distinguished group recognised for their personal achievement, outstanding leadership and continuing involvement in health and medicine-related sciences in
Category:
Posted on:
Kolling Institute researchers will help drive an exciting international project to identify the genetic links to Parkinson’s disease and new ways to treat the debilitating disorder. The program will bring together leading researchers from Sweden, the United States and Australia after a $12.5 million grant from the Aligning Science Across Parkinson’s initiative, which will be
Category:
Posted on:
Clinician and Kolling Institute researcher Professor Ashley Craig said their results follow a five year study involving more than 2,000 people injured in a motor vehicle accident. “One in three people injured in a traffic accident suffer depression and experience post-traumatic stress symptoms,” Professor Craig said. “By following patients over a long period of time,
Category: